Aa-050gyr003-e371-2021 Acquisition of Patent Tender - 56628125

Procurement Summary

Country: Mexico

Summary: Aa-050gyr003-e371-2021 Acquisition of Patent Medicine

Deadline: 31 Aug 2021

Posting Date: 25 Aug 2021

Other Information

Notice Type: Tender

TOT Ref.No.: 56628125

Document Ref. No.: 2318514

Competition: ICB

Financier: Self Financed

Purchaser Ownership: -

Tender Value: Refer Document

CPV Classification

33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system
33680000 - Pharmaceutical articles

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

AA-050GYR003-E371-2021 Acquisition of patent medicine
Ad description: AA-050GYR003-E371-2021 Acquisition of patent medicine
010, 000.4352.00.00 Botulinum toxin Type A - Solution Injectable Each jar press with powder contains: Botulinum toxin Type to 12.5 NG (500 U). Container with a jar press.
010, 000.5290.00.00 SAQUINAVIR tablet Each tablet contains: saquinavir mesylate equivalent to 500 mg of saquinavir container with 120 tablets.
010, 000.5421.00.00 Lapatinib. Tablet Each tablet contains: Lapatinib Dithosylate equivalent to 250 mg of Lapatinib container with 70 tablets.
010, 000.5655.00.00 pazopanib. Tablet Each tablet contains: pazopanib hydrochloride equivalent to 400 mg of pazopanib container with 60 tablets.
010, 000, 5995.00.00 afflibercept. Injectable solution Each milliliter contains: AFLIBERCEPT 40 mg ensence with ampule flask with 0.278 ml (40 mg / ml).
010, 000.6080.00.00 Secukinumab. Injectable solution Each preloaded feather contains: Secukinumab 150 mg. Container with two preloaded feathers with 1 ml (150 mg / ml).
010.000.6084.00.00 Sevelmeter Tablet Each tablet contains: Sevelmeter carbonate 800 mg container ...

Documents

 Tender Notice